Publication date: Available online 16 June 2017
Source:Journal of Ethnopharmacology
Author(s): Juan Ramón Zapata-Morales, Angel Josabad Alonso-Castro, Fabiola Domínguez, Candy Carranza-Álvarez, Mario Isiordia-Espinoza, Alejandro Hernández-Morales, Cesar Solorio-Alvarado
Ethnopharmacological relevanceBidens odorata Cav (Asteraceae)is used for the empirical treatment of inflammation and pain.Aim of the studyThis work evaluatedthein vitro and in vivo toxicity, antioxidant activity, as well as the anti-inflammatory and antinociceptive effects of an ethanol extract from Bidens odorata leaves (BOE).Materials and methodsThe in vitro toxicity of BOE (10–1000µg/ml) was evaluated with the comet assay in PBMC. The in vivo acute toxicity of BOE (500–5000mg/kg) and the effect of BOE (10–1000µg/ml) on the level of ROS in PBMC were determined.The in vivo anti-inflammatory activity of BOE was assessed using the TPA-induced ear edema in mice. The antinociceptive activities of BOE (50–200mg/kg p.o.) were assessed using the acetic acid and formalin tests. The antinociceptive mechanism of BOE was determined using naloxone and glibenclamide.ResultsBOE lacked DNA damage, and showed low in vivo toxicity (LD50>5000mg/kg p.o.). BOE inhibited ROS production (IC50= 252.13 ± 20.54µg/ml), and decreased inflammation by 36.1 ± 3.66%. In both antinociceptive test, BOE (200mg/kg) exerted activity with similar activity than the reference drugs.ConclusionB. odorata exerts low in vitro and in vivo toxicity, antioxidant effects, moderate in vivo anti-inflammatory activity, and antinociceptive effects mediated by ATP-sensitive K+ channels.
Graphical abstract
http://ift.tt/2rp8Fib
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου